Vireo Growth INC

Market Movers (8-K)

See all →
OTC.Pink
Vireo Growth Inc. announced its Board of Directors has authorized a Normal Course Issuer Bid to repurchase up to 2,426,872 subordinate voting shares.
OTC.Pink
Vireo Growth Inc. announced the closing of a $85 million senior secured asset-based revolving credit facility and the completion of its acquisition of PharmaCann's Colorado retail assets, expanding its dispensary footprint.
OTC.Pink
Vireo Growth Inc. announced robust second-quarter 2026 financial results, showcasing substantial year-over-year revenue growth fueled by strategic acquisitions and detailing plans for further expansion.
Better than expected
Capital raise
OTC.Pink
Vireo Growth Inc. announced four definitive agreements to acquire 100% of the membership interests of four Ohio-based cannabis companies, establishing a significant vertically integrated presence in the state.
OTC.Pink
Vireo Growth Inc. announced its entry into a definitive merger agreement to acquire Planet 13 Holdings Inc., with the transaction expected to close by July 26, 2027.
Delay expected
OTC.Pink
Vireo Growth Inc. announced its definitive merger agreement to acquire Planet 13 Holdings Inc., aiming to expand its multi-state cannabis operations.

Quarterly Earnings (10-Q)

See all →
OTC.Pink
Vireo Growth Inc. reported a significant revenue increase of 333% to $106.2 million in Q1 2026, driven by strategic acquisitions and expanded operations.
Better than expected
OTC.Pink
Vireo Growth Inc. announced a significant revenue surge driven by recent acquisitions, despite reporting increased net losses for the quarter and nine months ended September 30, 2025.
Worse than expected
Capital raise
OTC.Pink
Vireo Growth Inc. announced a significant revenue surge in Q2 2025, driven by recent strategic acquisitions, despite a widening net loss and declining gross margins.
Delay expected
Worse than expected
Capital raise
OTC.Pink
Vireo Growth Inc. announces a marginal increase in revenue for Q1 2025, highlighting strategic realignments and merger agreements.
Worse than expected
OTC.Pink
Vireo Growth Inc. saw a modest revenue increase in Q3 2024, driven by growth in Maryland, while navigating ongoing strategic changes and legal challenges.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Vireo Growth Inc. saw a 24% increase in revenue in the second quarter of 2024, driven by growth in Maryland, while navigating ongoing legal challenges and strategic asset sales.
Better than expected
Capital raise

Annual Reports (10-K)

OTC.Pink
Vireo Growth Inc. reports a significant 170% revenue increase in 2025 driven by strategic mergers, despite incurring net losses, as it navigates a complex and evolving cannabis market.
Delay expected
Worse than expected
Capital raise
OTC.Pink
Vireo Growth Inc. files its 10-K report, detailing its financial performance for the year ended December 31, 2024, and outlining its strategic objectives for the coming year.
Delay expected
Capital raise
OTC.Pink
Goodness Growth Holdings files an amendment to its annual report on Form 10-K, including details on executive compensation and amendments to employment agreements.
OTC.Pink
Goodness Growth Holdings has disclosed a non-statutory stock option agreement for Kyle Kingsley and a non-plan stock option agreement for Joshua Rosen, alongside its annual 10-K filing, detailing the terms of executive compensation.
Worse than expected
Capital raise

Insider Trading (Form 4)

See all →
OTC.Pink
Vireo Growth Inc. presents an investor update detailing substantial Q2 2026 financial growth, strategic acquisitions, and a proposed merger with Planet 13 Holdings Inc. to create a leading U.S. cannabis operator.
Better than expected
Capital raise
OTC.Pink
Vireo Growth Inc. provides an update on its Agreement and Plan of Merger with Planet 13 Holdings Inc., detailing procedural filings and forward-looking statements.
OTC.Pink
Vireo Growth Inc. presents an investor presentation detailing its Q2 2026 performance, significant year-over-year revenue growth, and strategic acquisitions, including a proposed merger with Planet 13 Holdings Inc.
Better than expected
Capital raise
OTC.Pink
Vireo Growth Inc. reported strong Q2 2026 results, highlighted by a pro forma revenue exceeding $1 billion and significant strategic acquisitions that are set to expand its multi-state cannabis and agribusiness platform.
Better than expected
OTC.Pink
Vireo Growth Inc. announced robust second-quarter 2026 financial results, showcasing a 335% year-over-year revenue increase driven by strategic M&A, alongside significant expansion plans.
Better than expected
Capital raise
OTC.Pink
Vireo Growth Inc. has entered into a definitive agreement to acquire Planet 13 Holdings Inc. through a merger, with Planet 13 shareholders receiving a specified ratio of Vireo shares.

Proxy Statements (Def-14A)

See all →
OTC.Pink
Vireo Growth Inc. has filed its proxy statement for the 2026 Annual General and Special Meeting, seeking shareholder approval for a share consolidation, director elections, and executive compensation amendments.
Capital raise
OTC.Pink
Vireo Growth Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pursuant to Section 14(a) of the Securities Exchange Act of 1934.
OTC.Pink
Vireo Growth Inc. will hold its annual general meeting on June 20, 2025, to elect directors and appoint auditors.
Capital raise
OTC.Pink
Vireo Growth Inc. secures shareholder approval via written consent for mergers with Deep Roots, Proper Companies, and WholesomeCo, along with RSU grants to key executives.
Worse than expected
OTC.Pink
Goodness Growth Holdings, Inc. files a definitive proxy statement with the SEC.
OTC.Pink
Goodness Growth Holdings will hold its annual general and special meeting on June 21, 2024, to vote on key proposals including director elections and incentive plan approvals.

Schedule 13D - Activist Investments

OTC.Pink
Keith Capurro, Ryan Breeden, and KCRB LLC have disclosed beneficial ownership of over 6% of Vireo Growth Inc.'s subordinate voting shares following the acquisition of Deep Roots Holdings Inc.
OTC.Pink
A group led by Vireo Growth Inc.'s Chief Demand Officer, Christopher Jeffery, has disclosed beneficial ownership of 8.6% of the company's subordinate voting shares following the acquisition of WholesomeCo, Inc.
OTC.Pink
Chicago Atlantic Group and its affiliates have significantly increased their beneficial ownership in Vireo Growth Inc. to up to 36.7% through a series of debt conversions, new share issuances, and additional financing agreements, alongside a key management appointment.
Capital raise

Schedule 13G - Passive Investments

OTC.Pink
Roger Primm and RP Holding, LLC have reported a 6.5% beneficial ownership stake in Vireo Growth Inc.'s Subordinate Voting Shares.
OTC.Pink
Gary Primm and GEP Ventures, LLC have disclosed a 6.5% beneficial ownership stake in Vireo Growth Inc.'s Subordinate Voting Shares, totaling 59,630,517 shares.
OTC.Pink
Robert J. Barnard and Black Maple Capital Management LP have filed an amended Schedule 13G, disclosing their beneficial ownership of Subordinate Voting Shares in Vireo Growth Inc. as of December 31, 2024.
Capital raise